Loading company…
Rejuvenate Biomed develops combination drugs for healthy aging and age-related conditions.
Founded in 2017 and based in Belgium, Rejuvenate Biomed develops treatments for age-related health conditions. Its candidate RJx-01 is being evaluated for maintaining muscle integrity in older patients with muscle weakness and sarcopenia associated with COPD. In October 2021, the company raised EUR 15.7 million in Series B funding from Rejuveron Life Sciences, Vesalius Biocapital and other investors.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in